Open database of authors and journals




Results 1 to 19 of 19 articles found
2020

Safety trial of tadalafil administered for the treatment of preeclampsia

2019

Maternal Blood Concentration of Tadalafil and Uterine Blood Flow in Pregnancy

2017

[Case Report] Treatment using tadalafil for severe pre-eclampsia with fetal growth restriction

2019

Placental growth factor as a predictor of the efficacy of tadalafil treatment for fetal growth restriction

2021

Tadalafil treatment for preeclampsia (medication in preeclampsia; MIE): a multicenter phase II clinical trial

2017

Retrospective study of tadalafil for fetal growth restriction: Impact on maternal and perinatal outcomes

2019

36: Tadalafil treatment in mice for preeclampsia with fetal growth restriction has neurobenefic effects in offspring

2022

Maternal blood concentration of tadalafil in pregnancy: Comparison of pregnant and non-pregnant women.

2021

Phase-1 clinical study of tadalafil administered for selective fetal growth restriction in twin pregnancy

2017

Safety and dose-finding trial of tadalafil administered for fetal growth restriction: A phase-1 clinical study

2019

374: Tadalafil treatment for fetus with early onset growth restriction (TADAFER) A multicenter phase Ⅱ trial

2019

Cardiac function and tadalafil used for treating fetal growth restriction in pregnant women without cardiovascular disease

2016

[Case Report] Early-onset fetal growth restriction treated with the long-acting phosphodiesterase-5 inhibitor tadalafil: a case report

2018

TADAFER II: Tadalafil treatment for fetal growth restriction - a study protocol for a multicenter randomised controlled phase II trial

BMJ Open (2.9 ), 8, e020948. Cite Citations
2019

Safety Evaluation of Tadalafil Treatment for Fetuses with Early-Onset Growth Restriction (TADAFER): Results from the Phase II Trial

2017

Tadalafil Improves L-NG-Nitroarginine Methyl Ester-Induced Preeclampsia With Fetal Growth Restriction-Like Symptoms in Pregnant Mice

2019

Tadalafil treatment in mice for preeclampsia with fetal growth restriction has neuro-benefic effects in offspring through modulating prenatal hypoxic conditions

2021

Maternal tadalafil therapy for fetal growth restriction prevents non-alcoholic fatty liver disease and adipocyte hypertrophy in the offspring

Scientific Reports (4.7 ), 11, 1186. Cite Citations
2021

Assessment of the value of measuring soluble fms-like tyrosine kinase-1 and placental growth factor levels following administration of tadalafil to treat fetal growth restriction.

Anatomy of Results
The left numbers are the publication year, and the number of citations (hyperlink to the full citation report of the paper)
paranthesis after the journal provides its impact factor.
paranthesis after the author indicates the number of publications and citations
Narrow Search
For searching the publication of a single author or in a journal or in a discipline, find the target category from Authors, Journals, Disciplines, respectively.
EXALY
Profiles
Fields
Search Engines
Tools